So much for vaccine-generated herd immunity

In an Israeli hospital outbreak, 96% vaccination rates (and universal masking) made no difference. And guess who had mild cases? Hint: not the vaccinated.

By Alex Berenson

A reader tipped me to this fascinating paper in a peer-reviewed journal about a Covid outbreak in Israel that began in mid-July, just as vaccine failure was accelerating there.

A vaccinated dialysis patient was admitted to Meir Medical Center – a large Israeli hospital near Tel Aviv – with fever and cough. He remained on the dialysis unit for days, as his condition worsened. (One of many problems with overselling the vaccines is that it led to mistakes like this.)

 

<
>
 

By the time he was diagnosed with Covid-19, he had infected three fellow patients. He also had a PCR threshold of 13.6 – almost impossibly low, showing viral loads roughly 1 million times those in a lightly infected person. He was moved to a Covid-19 ward, where he eventually died (I say he, though the patient’s gender is not revealed; the paper refers to “they).

The paper, published in Eurosurveillance, a journal published by the European Centers for Disease Control, explains that the outbreak rapidly spread among both patients and staff of the hospital’s dialysis unit, the Covid-19 ward, and other wards. At the time, 238 out of 248 of exposed patients and staff had been fully vaccinated with Pfizer’s mRNA vaccine.

Again, the fact that 96 percent of the people in this population had been vaccinated – a level far above early estimates of the percentages required for herd immunity – apparently made no difference.

Further, all patients and staff were required to wear surgical masks when they were in the same room, and staff on the Covid-19 unit wore N95 masks and face shields.

Ultimately, 39 out of the 238 exposed vaccinated people (16 percent) were infected, along with 3 out of 10 unvaccinated people – a difference that doesn’t reach statistical significance because the unvaccinated group is too small.

Of the infected, 23 were patients and 19 staff. The staff all recovered quickly. But five patients died and another nine had severe or critical cases. All were vaccinated. The two unvaccinated infected patients both had mild cases.

 

<
>
 

As the authors explained:

“This communication… challenges the assumption that high universal vaccination rates will lead to herd immunity and prevent COVID-19 outbreaks… In the outbreak described here, 96.2% of the exposed population was vaccinated. Infection advanced rapidly (many cases became symptomatic within 2 days of exposure), and viral load was high.”

SOURCE:

eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.39.2100822#html_fulltext

October 4, 2021 | 7 Comments »

Leave a Reply

7 Comments / 7 Comments

  1. Israeli Study: Chance of Myocarditis After COVID-19 Vaccine Extremely Rare

    The chance of contracting myocarditis, an inflammation of the heart muscle, after receiving a Coronavirus (COVID-19) vaccine is extremely rare, new Israeli research reveals.

    Researchers at Beilinson Hospital and the Clalit Health Insurance Fund published on Wednesday the findings of a large-scale study that includes data from two and a half million vaccinated Israelis, which shows that the risk of myocarditis after receiving a Pfizer-developed vaccination is extremely rare and does not cause significant muscle damage in the short and medium-term.

    The incidence of myocarditis is 2.13 cases per 100,000 vaccinated, with 98% of them having a mild to moderate disease without any impairment of heart function.

    One person suffered from a serious illness that required hospitalization, after which he recovered. The rare side effect occurred more after the second vaccine dose, 69% more than after the first, in men more than in women, and more between the ages of 16 and 29.

    Dr. Guy Whitberg, Cardiologist at Beilinson Hospital, said that “this study is the first to reliably assess the incidence of myocarditis, the main side effect that was found to be related to the corona vaccine.”

    The study’s findings show that it is a relatively rare side effect even in the population group at the highest risk, young men.

    Furthermore, the study findings show that “in the vast majority of cases, it is a mild disease with a benign course that does not significantly affect cardiac function in the short term and is not expected to affect patients’ health in the long term,” he noted.

    Professor Ran Kornowski, director of the cardiology department at Beilinson Hospital, noted that these are “significant results and that researchers hope they will enable informed decisions about the enormous and proven benefit of the vaccine’s high efficacy, and the importance of preventing viral morbidity, relative to the side effect of myocarditis.”

    https://www.jewishpress.com/news/health-and-medicine/coronavirus/israeli-study-chance-of-myocarditis-after-covid-19-vaccine-extremely-rare/2021/10/07/

  2. Dr. McCullough and Dr. Rose do study on Myocarditis:

    We used VAERS data to examine cardiac AEs, primarily myocarditis, reported following injection of the first or second dose of the COVID-19 injectable products. Myocarditis rates reported in VAERS were significantly higher in youths between the ages of 13 to 23 (p<0.0001) with ?80% occurring in males. Within 8 weeks of the public offering of COVID-19 products to the 12-15-year-old age group, we found 19 times the expected number of myocarditis cases in the vaccination volunteers over background myocarditis rates for this age group. In addition, a 5-fold increase in myocarditis rate was observed subsequent to dose 2 as opposed to dose 1 in 15-year-old males. A total of 67% of all cases occurred with BNT162b2. Of the total myocarditis AE reports, 6 individuals died (1.1%) and of these, 2 were under 20 years of age – 1 was 13. These findings suggest a markedly higher risk for myocarditis subsequent to COVID-19 injectable product use than for other known vaccines, and this is well above known background rates for myocarditis. COVID-19 injectable products are novel and have a genetic, pathogenic mechanism of action causing uncontrolled expression of SARS-CoV-2 spike protein within human cells. When you combine this fact with the temporal relationship of AE occurrence and reporting, biological plausibility of cause and effect, and the fact that these data are internally and externally consistent with emerging sources of clinical data, it supports a conclusion that the COVID-19 biological products are deterministic for the myocarditis cases observed after injection.

    https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8483988/

    Pehaps this is why the Vaccine Committee ignored the findings of the junk retrospective study.

  3. It would seem that the Israeli Vaccine Committee doesn’t trust the findings of the myocarditis retrospective study either. Good for them! Now, maybe they should actually test the subjects and medicate the ones they find have myocarditis. Early treatment can have a significant effect, and even if the early treatmement is not successful, it is better to know if you have a chronic heart disease so it can be monitored and treated accordingly. The worst way to deal with a problem is to ignore it, especially when the problem is drug induce myocardits.

    The professional members of the immunization committee also discussed a recommendation for all vaccinators – and especially for adolescent boys and men under 30, to avoid strenuous activity and sports training such as weightlifting, and cardio-lung training such as sprinting or long-distance swimming, the week after receiving the first and second vaccine.

    In a presentation we received – it is written that athletes who are afraid of getting out of shape may consider lowering the level of effort in training this week or performing low-intensity training.

    Dr. Alon Rapaport, medical director of Pfizer Israel, also referred to myocarditis, in an interview at the main edition studio: “The story of myocarditis is a rare side effect – usually transient, and can be treated by conventional means.”

    https://www.mako.co.il/news-lifestyle/2021_q4/Article-758ed54f6c65c71027.htm?utm_source=Twitter&utm_medium=NewsChannelPost&partne=rNewsChannelTwitter

  4. Why do we have to play games on this very significant topic? Myocarditis kills people. The younger the patient the more tragic the outcome. Why would they use a retrospective study to confirm myocarditis? They screened 2.5million records to find if anyone was incidentally diagnosed with myocarditis. While a vaccine program was being conducted that no one is allowed to even criticize. This retrospective reveiw was carried out between Dec and May, before the issue of Myocarditis was publicly known. The vax wasn’t labeled in this time period for Myocardits, which is a very difficult thing to diagnose when you are actually looking for it. It can only be confirmed with a biopsy or via cardiac MRI(CMR) yet ,we are to believe that the health officials would sincerely record a diagnosis of myocarditis which would necessarily be linked to the vaccines. Think about how careful we are being to not find any trace of myocarditis. A study would not be difficult to setup to actually test for myocarditis if we really wanted to gather results.

    There are two ways to have easily setup a study to pursue this properly, one thorough and one very quick.
    1. Children are being injected with a compound known to cause serious injuries. Why would they not test the children as they were being vaccinated. Collect 5K children in two groups, weight and balance the two groups equivalently, do a cardiac workup pre-vaccine and followup with the CMR – a cardiac MRI used to test for acute(recent) myocarditis – for diagnosis afterwards. No games, no false biases, which are always present in retrospective studies, and no chance of missed diagnoses, most importantly – just good clean data that could be judged and assessed.

    2. Second scenario – just choose a city or town and test the children that were vaccinated. Pull 5K kids and check them. We know the background incidence of myocarditis. So just check a significant number of kids that have been vaccinated.

    I said it before, and I say it again. We don’t know because we don’t want to know. The health of the patient is secondary to providing political cover for a program that has already been acceded to for whatever reason that might be. The patient’s care is only a secondary consideration – and on that point, nothing has changed.

    Major Israeli study: Risk of heart inflammation after COVID shots is very minor
    Data from 2.5 million who got vaccine finds phenomenon afflicted only 0.002%, and was found to be serious in only 2% of those cases that did develop
    By TOI staff Today, 3:05 am

    A new Israeli studies has found the risk of heart inflammation as a result of Pfizer’s coronavirus vaccine to be exceedingly low and eminently treatable

    https://www.timesofisrael.com/major-israeli-study-finds-risk-of-heart-inflammation-after-covid-shots-is-minute/

  5. COPENHAGEN, Denmark (AP) — Scandinavian authorities on Wednesday suspended or discouraged the use of Moderna’s COVID-19 vaccine in young people because of an increased risk of heart inflammation, a very rare side effect associated with the shot.

    Sweden suspended the use of Moderna for those recipients under 30, Denmark said those under 18 won’t be offered the Swiss-made vaccine, and Norway urged those under 30 to get the Pfizer vaccine instead.

    The countries have adequate supplies of both Pfizer and Moderna vaccines and will be able to continue their vaccination campaigns.

    In neighboring Finland, authorities are expected to announce their decision Thursday, according to Dr. Hanna Nohynek, chief physician at the Finnish Institute for Health and Welfare, told local broadcaster YLE.

    All three countries based their decision on an unpublished study with Sweden’s Public Health Agency saying that it signals “an increased risk of side effects such as inflammation of the heart muscle or the pericardium” — the double-walled sac containing the heart and the roots of the main vessels. It added: “The risk of being affected is very small.”

    Anders Tegnell, Sweden’s chief epidemiologist, said they “follow the situation closely and act quickly to ensure that vaccinations against COVID-19 are always as safe as possible and at the same time provide effective protection” against the disease.

    The preliminary information from the Nordic study has been sent to the European Medicines Agency’s adverse reaction committee to be assessed.

    The study was conducted by Denmark’s Statens Serum Institut, a government agency that maps the spread of the coronavirus in the country; the Medical Products Agency in Sweden; Norway’s National Institute of Public Health; and the Institute for Health and Welfare in Finland. The final results were expected in about a month, said Bolette Soeborg of the Danish government health agency.

  6. I agree, kbfcst. Five booster shots required? How ridiculous can they get? They’re dishing out “vaccines” like One-a-Day Vitamins.

  7. Obviously, this desperate drive to induce and coerce us to take the jab is not at all about “public health.”